ArticleEmerging microbes & infections2026

Peripheral human mAb therapy yields modulation of neuroinflammation and long-term functional recovery from lyssavirus infection.

Celeste Huaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.